Logo image of DCBO.CA

DOCEBO INC (DCBO.CA) Stock Fundamental Analysis

Canada - TSX:DCBO - CA25609L1058 - Common Stock

36.9 CAD
+0.6 (+1.65%)
Last: 10/17/2025, 7:00:00 PM
Fundamental Rating

6

Overall DCBO gets a fundamental rating of 6 out of 10. We evaluated DCBO against 62 industry peers in the Software industry. DCBO is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. DCBO is not priced too expensively while it is growing strongly. Keep and eye on this one! With these ratings, DCBO could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year DCBO was profitable.
In the past year DCBO had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: DCBO reported negative net income in multiple years.
DCBO had a positive operating cash flow in 4 of the past 5 years.
DCBO.CA Yearly Net Income VS EBIT VS OCF VS FCFDCBO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

DCBO has a Return On Assets of 12.51%. This is amongst the best in the industry. DCBO outperforms 90.32% of its industry peers.
DCBO has a Return On Equity of 61.75%. This is amongst the best in the industry. DCBO outperforms 98.39% of its industry peers.
DCBO has a better Return On Invested Capital (32.53%) than 96.77% of its industry peers.
Industry RankSector Rank
ROA 12.51%
ROE 61.75%
ROIC 32.53%
ROA(3y)6.1%
ROA(5y)2.04%
ROE(3y)18.51%
ROE(5y)8.92%
ROIC(3y)N/A
ROIC(5y)N/A
DCBO.CA Yearly ROA, ROE, ROICDCBO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 150

1.3 Margins

The Profit Margin of DCBO (9.29%) is better than 83.87% of its industry peers.
DCBO has a better Operating Margin (9.67%) than 75.81% of its industry peers.
Looking at the Gross Margin, with a value of 81.00%, DCBO belongs to the top of the industry, outperforming 88.71% of the companies in the same industry.
DCBO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.67%
PM (TTM) 9.29%
GM 81%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.38%
GM growth 5Y0.22%
DCBO.CA Yearly Profit, Operating, Gross MarginsDCBO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

7

2. Health

2.1 Basic Checks

DCBO has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, DCBO has about the same amount of shares outstanding.
The number of shares outstanding for DCBO has been increased compared to 5 years ago.
DCBO has a better debt/assets ratio than last year.
DCBO.CA Yearly Shares OutstandingDCBO.CA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
DCBO.CA Yearly Total Debt VS Total AssetsDCBO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

DCBO has an Altman-Z score of 3.27. This indicates that DCBO is financially healthy and has little risk of bankruptcy at the moment.
DCBO has a Altman-Z score (3.27) which is in line with its industry peers.
The Debt to FCF ratio of DCBO is 0.05, which is an excellent value as it means it would take DCBO, only 0.05 years of fcf income to pay off all of its debts.
DCBO has a better Debt to FCF ratio (0.05) than 95.16% of its industry peers.
DCBO has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
DCBO has a Debt to Equity ratio of 0.01. This is in the better half of the industry: DCBO outperforms 77.42% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.05
Altman-Z 3.27
ROIC/WACC3.06
WACC10.62%
DCBO.CA Yearly LT Debt VS Equity VS FCFDCBO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

DCBO has a Current Ratio of 1.04. This is a normal value and indicates that DCBO is financially healthy and should not expect problems in meeting its short term obligations.
DCBO's Current ratio of 1.04 is in line compared to the rest of the industry. DCBO outperforms 43.55% of its industry peers.
DCBO has a Quick Ratio of 1.04. This is a normal value and indicates that DCBO is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.04, DCBO is in line with its industry, outperforming 43.55% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.04
Quick Ratio 1.04
DCBO.CA Yearly Current Assets VS Current LiabilitesDCBO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 103.70% over the past year.
Looking at the last year, DCBO shows a quite strong growth in Revenue. The Revenue has grown by 15.11% in the last year.
DCBO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 39.25% yearly.
EPS 1Y (TTM)103.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.33%
Revenue 1Y (TTM)15.11%
Revenue growth 3Y27.67%
Revenue growth 5Y39.25%
Sales Q2Q%14.47%

3.2 Future

Based on estimates for the next years, DCBO will show a very strong growth in Earnings Per Share. The EPS will grow by 27.76% on average per year.
The Revenue is expected to grow by 24.94% on average over the next years. This is a very strong growth
EPS Next Y37.82%
EPS Next 2Y33.47%
EPS Next 3Y34.47%
EPS Next 5Y27.76%
Revenue Next Year11.22%
Revenue Next 2Y9.78%
Revenue Next 3Y9.84%
Revenue Next 5Y24.94%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
DCBO.CA Yearly Revenue VS EstimatesDCBO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
DCBO.CA Yearly EPS VS EstimatesDCBO.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

DCBO is valuated rather expensively with a Price/Earnings ratio of 23.81.
Based on the Price/Earnings ratio, DCBO is valued cheaper than 85.48% of the companies in the same industry.
DCBO is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.40, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 17.14, the valuation of DCBO can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DCBO indicates a somewhat cheap valuation: DCBO is cheaper than 79.03% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.94, DCBO is valued a bit cheaper.
Industry RankSector Rank
PE 23.81
Fwd PE 17.14
DCBO.CA Price Earnings VS Forward Price EarningsDCBO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DCBO is valued a bit cheaper than 67.74% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DCBO indicates a somewhat cheap valuation: DCBO is cheaper than 74.19% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 28.04
EV/EBITDA 26.45
DCBO.CA Per share dataDCBO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

DCBO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
DCBO has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as DCBO's earnings are expected to grow with 34.47% in the coming years.
PEG (NY)0.63
PEG (5Y)N/A
EPS Next 2Y33.47%
EPS Next 3Y34.47%

0

5. Dividend

5.1 Amount

No dividends for DCBO!.
Industry RankSector Rank
Dividend Yield N/A

DOCEBO INC

TSX:DCBO (10/17/2025, 7:00:00 PM)

36.9

+0.6 (+1.65%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-08 2025-08-08/bmo
Earnings (Next)11-07 2025-11-07
Inst Owners31.4%
Inst Owner ChangeN/A
Ins Owners1.51%
Ins Owner ChangeN/A
Market Cap1.06B
Analysts78.67
Price Target41.36 (12.09%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)27.06%
Min EPS beat(2)26.05%
Max EPS beat(2)28.07%
EPS beat(4)3
Avg EPS beat(4)41.65%
Min EPS beat(4)-25.3%
Max EPS beat(4)137.79%
EPS beat(8)7
Avg EPS beat(8)31.82%
EPS beat(12)10
Avg EPS beat(12)131.11%
EPS beat(16)13
Avg EPS beat(16)110.84%
Revenue beat(2)1
Avg Revenue beat(2)-0.14%
Min Revenue beat(2)-1.61%
Max Revenue beat(2)1.34%
Revenue beat(4)2
Avg Revenue beat(4)-0.11%
Min Revenue beat(4)-1.61%
Max Revenue beat(4)1.34%
Revenue beat(8)2
Avg Revenue beat(8)-0.44%
Revenue beat(12)2
Avg Revenue beat(12)-0.71%
Revenue beat(16)3
Avg Revenue beat(16)-0.87%
PT rev (1m)0%
PT rev (3m)3.17%
EPS NQ rev (1m)0%
EPS NQ rev (3m)13.43%
EPS NY rev (1m)1.75%
EPS NY rev (3m)-1.21%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.57%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.48%
Valuation
Industry RankSector Rank
PE 23.81
Fwd PE 17.14
P/S 3.27
P/FCF 28.04
P/OCF 26.7
P/B 21.75
P/tB 40.12
EV/EBITDA 26.45
EPS(TTM)1.55
EY4.2%
EPS(NY)2.15
Fwd EY5.83%
FCF(TTM)1.32
FCFY3.57%
OCF(TTM)1.38
OCFY3.74%
SpS11.27
BVpS1.7
TBVpS0.92
PEG (NY)0.63
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 12.51%
ROE 61.75%
ROCE 55.51%
ROIC 32.53%
ROICexc N/A
ROICexgc N/A
OM 9.67%
PM (TTM) 9.29%
GM 81%
FCFM 11.67%
ROA(3y)6.1%
ROA(5y)2.04%
ROE(3y)18.51%
ROE(5y)8.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.38%
GM growth 5Y0.22%
F-Score8
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.05
Debt/EBITDA 0.01
Cap/Depr 39.68%
Cap/Sales 0.58%
Interest Coverage 250
Cash Conversion 110.06%
Profit Quality 125.62%
Current Ratio 1.04
Quick Ratio 1.04
Altman-Z 3.27
F-Score8
WACC10.62%
ROIC/WACC3.06
Cap/Depr(3y)34.45%
Cap/Depr(5y)55.59%
Cap/Sales(3y)0.56%
Cap/Sales(5y)1.02%
Profit Quality(3y)220.57%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)103.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.33%
EPS Next Y37.82%
EPS Next 2Y33.47%
EPS Next 3Y34.47%
EPS Next 5Y27.76%
Revenue 1Y (TTM)15.11%
Revenue growth 3Y27.67%
Revenue growth 5Y39.25%
Sales Q2Q%14.47%
Revenue Next Year11.22%
Revenue Next 2Y9.78%
Revenue Next 3Y9.84%
Revenue Next 5Y24.94%
EBIT growth 1Y84.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year125.27%
EBIT Next 3Y50.67%
EBIT Next 5Y32.58%
FCF growth 1Y380.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y338.61%
OCF growth 3YN/A
OCF growth 5YN/A